Medical device licence · 71319 · Class 2
LYSOZYME, POLYCLONAL ANTIBODY
No longer licensed: cancelled: renewal not answered
Licence status Cancelled: renewal not answered; first licensed May 5, 2006; ended October 31, 2018. It is in Health Canada’s archive of licences no longer in force.
- Licence number
- 71319
- Licence holder
- Biogenex Laboratories Inc.Fremont, CA, United States
- Risk class
- Class II (low to moderate risk)
- Licence type
- Device Family
- First licensed
- May 5, 2006
- Ended
- October 31, 2018
- Devices covered
- 3
Devices on this licence
By name, as listed. The official record lists model numbers and identifiers.
- LYSOZYME (AUTOMATED) (POLYCLONAL)
- LYSOZYME (CONCENTRATED) (POLYCLONAL)
- LYSOZYME (MANUAL) (POLYCLONAL)
Class I devices, the lowest-risk group, mostly need no device licence, so most are not in this list.